Metabolic syndrome among psychiatric outpatients with mood and anxiety disorders

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Hung, Ching I ^a,b   Liu, Chia Yih ^a,b   Hsiao, Mei Chun ^a,b   Yu, Nan Wen ^a   Chu, Chun Lin ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Anxiety; Bipolar disorder; Depression; Metabolic syndrome

Indexed keywords

ANTIDEPRESSANT AGENT; DULOXETINE; ESCITALOPRAM; FLUOXETINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; QUETIAPINE; SULPIRIDE; TRAZODONE; VALPROIC ACID; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BODY MASS; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG COST; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; METABOLIC SYNDROME X; MOOD DISORDER; OUTPATIENT; PREVALENCE; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; ANXIETY DISORDERS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; MIDDLE AGED; TAIWAN; YOUNG ADULT;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ANXIETY DISORDERS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OUTPATIENTS; PREVALENCE; TAIWAN; YOUNG ADULT;

EID: 84902734832     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-14-185     Document Type: Article

References (38)

1. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
2. Wang Y, Yu Q, Chen Y, Cao F. Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome. Curr Pharm Des 2013, 19:4799-4805.
3. Singh RB, Gupta S, Dherange P, De Meester F, Wilczynska A, Alam SE, Pella D, Wilson DW. Metabolic syndrome: a brain disease. Can J Physiol Pharmacol 2012, 90:1171-1183.
4. Chang HH, Chou CH, Chen PS, Gean PW, Huang HC, Lin CY, Yang YK, Lu RB. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J Affect Disord 2009, 117:124-129.
5. McElroy SL, Keck PE. Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression. J Clin Psychiatry 2014, 75:46-61.
6. Chadda RK, Ramshankar P, Deb KS, Sood M. Metabolic syndrome in schizophrenia: differences between antipsychotic-naive and treated patients. J Pharmacol Pharmacother 2013, 4:176-186.
7. Malhotra N, Kulhara P, Chakrabarti S, Grover S. A prospective, longitudinal study of metabolic syndrome in patients with bipolar disorder and schizophrenia. J Affect Disord 2013, 150:653-658.
8. Kim B, Kim SJ, Son JI, Joo YH. Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients. J Affect Disord 2008, 105:45-52.
9. Al-Zoairy R, Ress C, Tschoner A, Kaser S, Ebenbichler C. The effects of psychotropic drugs on the regulation of glucose metabolism. Curr Diabetes Rev 2013, 9:362-370.
10. Hasnain M, Vieweg WV. Weight considerations in psychotropic drug prescribing and switching. Postgrad Med 2013, 125:117-129.
11. van Winkel R, van Os J, Celic I. Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program. J Clin Psychiatry 2008, 69:1319-1327.
12. Taylor V, MacQueen G. Associations between bipolar disorder and metabolic syndrome: a review. J Clin Psychiatry 2006, 67:1034-1041.
13. McIntyre RS, Rasgon NL, Kemp DE, Nguyen HT, Law CW, Taylor VH, Woldeyohannes HO, Alsuwaidan MT, Soczynska JK, Kim B, Lourenco MT, Kahn LS, Goldstein BI. Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr Diab Rep 2009, 9:51-59.
14. Viinamaki H, Heiskanen T, Lehto SM, Niskanen L, Koivumaa-Honkanen H, Tolmunen T, Honkalampi K, Saharinen T, Haatainen K, Hintikka J. Association of depressive symptoms and metabolic syndrome in men. Acta Psychiatr Scand 2009, 120:23-29.
15. Takeuchi T, Nakao M, Kachi Y, Yano E. Association of metabolic syndrome with atypical features of depression in Japanese people. Psychiatry Clin Neurosci 2013, 67:532-539.
16. Kahl KG, Greggersen W, Schweiger U, Cordes J, Balijepalli C, Lösch C, Moebus S. Prevalence of the metabolic syndrome in unipolar major depression. Eur Arch Psychiatry Clin Neurosci 2012, 262:313-320.
17. Goldbacher EM, Bromberger J, Matthews KA. Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women. Psychosom Med 2009, 71:266-272.
18. McIntyre RS, Filteau MJ, Martin L, Patry S, Carvalho A, Cha DS, Barakat M, Miguelez M. Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach. J Affect Disord 2014, 156:1-7.
19. Herva A, Rasanen P, Miettunen J, Timonen M, Läksy K, Veijola J, Laitinen J, Ruokonen A, Joukamaa M. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Cohort Study. Psychosom Med 2006, 68:213-216.
20. Hildrum B, Mykletun A, Midthjell K, Ismail K, Dahl AA. No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study. Acta Psychiatr Scand 2009, 120:14-22.
21. Butnoriene J, Bunevicius A, Norkus A, Bunevicius R. Depression but not anxiety is associated with metabolic syndrome in primary care based community sample. Psychoneuroendocrinology 2014, 40:269-276.
22. Carroll D, Phillips AC, Thomas GN, Gale CR, Deary I, Batty GD. Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam experience study. Biol Psychiatry 2009, 66:91-93.
23. Albert U, Aguglia A, Chiarle A, Bogetto F, Maina G. Metabolic syndrome and obsessive-compulsive disorder: a naturalistic Italian study. Gen Hosp Psychiatry 2013, 35:154-159.
24. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) 2002, New York: Biometrics Research, New York State Psychiatric Institute.
25. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition, Text Revision 2000, Washington, DC: American Psychiatric Association, American Psychiatric Association.
26. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6:278-296.
27. Hung CI, Liu CY, Wang SJ, Yao YC, Yang CH. The cut-off points of the Depression and Somatic Symptoms Scale and the Hospital Anxiety and Depression Scale in detecting non-full remission and a current major depressive episode. Int J Psychiatry Clin Pract 2012, 16:33-40.
28. Hung CI, Liu CY, Wang SJ, Juang YY, Yang CH. Somatic symptoms: an important index in predicting the outcome of depression at six-month and two-year follow-up points among outpatients with major depressive disorder. J Affect Disord 2010, 125:134-140.
29. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
30. Duncan EJ, Woolson SL, Hamer RM, Dunlop BW. Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population. Int Clin Psychopharmacol 2009, 24:204-213.
31. Stahl SM, Mignon L, Meyer JM. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?. Acta Psychiatr Scand 2009, 119:171-179.
32. Torrent C, Amann B, Sanchez-Moreno J, Colom F, Reinares M, Comes M, Rosa AR, Scott J, Vieta E. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. Acta Psychiatr Scand 2008, 118:4-18.
33. Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 2006, 105:626-635.
34. Barnes RD, Boeka AG, McKenzie KC, Genao I, Garcia RL, Ellman MS, Ellis PJ, Masheb RM, Grilo CM. Metabolic syndrome in obese patients with binge-eating disorder in primary care clinics: a cross-sectional study. Prim Care Companion CNS Disord 2011, 13(2).
35. Blomquist KK, Milsom VA, Barnes RD, Boeka AG, White MA, Masheb RM, Grilo CM. Metabolic syndrome in obese men and women with binge eating disorder: developmental trajectories of eating and weight-related behaviors. Compr Psychiatry 2012, 53:1021-1027.
36. Richter N, Juckel G, Assion H-J. Metabolic syndrome: a follow-up study of acute depressive inpatients. Eur Arch Psychiatry Clin Neurosci 2010, 260:41-49.
37. Garcia-Portilla MP, Saiz PA, Benabarre A, Sierra P, Perez J, Rodriguez A, Livianos L, Torres P, Bobes J. The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord 2008, 106:197-201.
38. Wu RR, Zhao JP, Liu ZN, Zhai JG, Guo XF, Guo WB, Tang JS. Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia. Psychopharmacology 2006, 186:572-578.